Margaret Schot
- Oncology top 5%
- Molecular Biology
- Cancer Research top 5%
- Biomaterials top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Jos H. BeijnenJan H.M. SchellensW.W. ten Bokkel HuininkHilde RosingC.M.F. KruijtzerRoxanne C. JewellElaine PaulFranciska J. Koopman
- Topics
- Cancer Treatment and Pharmacology (15 papers)Drug Transport and Resistance Mechanisms (5 papers)Cancer therapeutics and mechanisms (5 papers)
- Cited by
- OncologyCancer ResearchBiomaterials
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
Margaret Schot
24 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Oncology 790
- Molecular Biology 391
- Cancer Research 378
- Biomaterials 275
- Pathology and Forensic Medicine 270
Countries citing papers authored by Margaret Schot
This map shows the geographic impact of Margaret Schot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Schot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Schot more than expected).
Fields of papers citing papers by Margaret Schot
This network shows the impact of papers produced by Margaret Schot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Schot. The network helps show where Margaret Schot may publish in the future.
Co-authorship network of co-authors of Margaret Schot
This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Schot. A scholar is included among the top collaborators of Margaret Schot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Schot. Margaret Schot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 18 | |
| 3 | 298 | |
| 4 | 9 | |
| 5 | 11 | |
| 6 | 59 | |
| 7 | 22 | |
| 8 | 26 | |
| 9 | 32 | |
| 10 | 37 | |
| 11 | Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer. | 7 |
| 12 | 86 | |
| 13 | 94 | |
| 14 | 13 | |
| 15 | 192 | |
| 16 | 55 | |
| 17 | 6 | |
| 18 | 11 | |
| 19 | 19 | |
| 20 | 4 |
About Margaret Schot
Margaret Schot is a scholar working on Oncology, Behavioral Neuroscience and Cancer Research, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Oncology (790 citations), Cancer Research (378 citations) and Biomaterials (275 citations). Margaret Schot has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Jos H. Beijnen, Jan H.M. Schellens, W.W. ten Bokkel Huinink, Hilde Rosing, C.M.F. Kruijtzer, Roxanne C. Jewell, Elaine Paul, Franciska J. Koopman, Marie-Jeanne T. F. D. Vrancken Peeters and Marieke E. Straver. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.